MSB 2.23% $1.10 mesoblast limited

Back pain stem cell injection, page-129

  1. 1,968 Posts.
    lightbulb Created with Sketch. 857
    From a non experts view, if the brain makes the decision, then if the part of the brain which controls this is disabled we will not feel pain. Hence developing a medication that will target the area which controls the pain. However with DDD if you control the pain you still have the problem of mobility.
    I do not agree with your concluding comment, while the Phase I is more for safety the FDA will approve only a product if it passes safety and efficacy standards.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.